Risk factors and metabolomics of mild cognitive impairment in type 2 diabetes mellitus

• DOI: 10.3389/fmolb.2024.1341290
• Publication Date: 2024-04-18T04:21:40Z
• Authors: Tao Luo; Xiao Jiang; Ning Xu; Xinyu Zhao; Xingjie Xie; Xiuwen Xia; XiaoLong Bian; Haixia Liu
• Keywords: 0301 basic medicine; 03 medical and health sciences; mild cognitive impairment; LPC; type 2 diabetes mellitus; QH301-705.5; risk factors; Molecular Biosciences; Biology (General); metabolomics

This study aimed to explore the risk factors, metabolic characteristics, and potential biomarkers of mild cognitive impairment in type 2 diabetes mellitus (T2DM-MCI) provide evidence for diagnosis, prevention, treatment (MCI) patients with (T2DM).